Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
5,9580.7%
Followers on X. Updated Oct 17, 2026
Loading...

Apimeds Pharmaceuticals X Follower Count

Apimeds Pharmaceuticals has 5,958 followers on X (formerly Twitter), down 16.4% over the past three months. Losing followers on X can indicate declining public interest or brand sentiment challenges.

With 5,958 followers, Apimeds Pharmaceuticals has a smaller X following than industry peers like Johnson & Johnson (241,491) and Eli Lilly and Company (146,300).

How Apimeds Pharmaceuticals’s X Growth Feeds the APUS AI Score

X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Apimeds Pharmaceuticals’s X following into the APUS AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.

For Apimeds Pharmaceuticals’s reach on other platforms, see Apimeds Pharmaceuticals Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.

For real-time conversation volume, see APUS X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.

Month over Month X Followers

Sep 2026 6,958
Aug 2026 7,012
Jul 2026 7,037
Jun 2026 7,173
May 2026 7,260
Get APUS alerts in real-time
The moment the x followers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Apimeds Pharmaceuticals X (Twitter) Followers: Frequently Asked Questions

Apimeds Pharmaceuticals has 5,958 followers (6K) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.

Apimeds Pharmaceuticals's X following is declining, down 16.4% over the past three months. View the trend chart above for the full history.

X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Apimeds Pharmaceuticals's following can reflect shifting public interest. That is why AltIndex combines Apimeds Pharmaceuticals's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Apimeds Pharmaceuticals underperforms its industry peers when it comes to X Followers, ranking in the 1st percentile.

Having under 10,000 followers, Apimeds Pharmaceuticals has a modest audience on X. This level of following suggests the potential to reach a wider, yet focused audience, important for establishing brand presence.

Sign up and get more insights on Apimeds Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.